(Q46493820)

22 December 2017

title

Effects of different subanesthetic doses of (S)-ketamine on neuropsychology, psychopathology, and state of consciousness in man. (English)

1 reference

22 December 2017

1 reference

1 reference

Torsten Passie

1

1 reference

22 December 2017

Matthias Karst

2

1 reference

22 December 2017

Birgitt Wiese

3

1 reference

22 December 2017

Hinderk M Emrich

4

1 reference

22 December 2017

Udo Schneider

5

1 reference

22 December 2017

publication date

12 May 2005

1 reference

22 December 2017

published in

Neuropsychobiology

1 reference

22 December 2017

volume

51

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

226-233

1 reference

22 December 2017

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

cites work

1 reference

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

21 January 2018

1 reference

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

21 January 2018

1 reference

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

21 January 2018

1 reference

The effects of a sub-anaesthetic dose of ketamine on human selective attention.

21 January 2018

1 reference

Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions

21 January 2018

1 reference

Subanesthetic doses of ketamine stimulate psychosis in schizophrenia

21 January 2018

1 reference

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

21 January 2018

1 reference

Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients.

21 January 2018

1 reference

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

21 January 2018

1 reference

Influence of treatment of Tourette syndrome with delta9-tetrahydrocannabinol (delta9-THC) on neuropsychological performance

21 January 2018

1 reference

Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects.

21 January 2018

1 reference

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

21 January 2018

1 reference

Psychedelic effects of ketamine in healthy volunteers: relationship to steady-state plasma concentrations

21 January 2018

1 reference

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

A systems model of altered consciousness: integrating natural and drug-induced psychoses

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000085724

1 reference

22 December 2017

1 reference

22 December 2017